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Abstract
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Periodontal disease is a bacterial induced chronic inflammatory condition that occurs in a
susceptible host, affecting the teeth, gingiva, periodontal ligament, and alveolar bone. The
resultant pathological bone defects often require surgical intervention, with the ultimate goal
being regeneration of the periodontium through the application of grafting materials and
biologics. Mesenchymal stem cells (MSCs) show great potential in regenerative medicine for
their ability to enhance cell proliferation and differentiation, increase angiogenesis, and modulate
the immune response. Stem cell-derived by-products, known as exosomes are a specific class of
lipid-membrane-bound extracellular vesicles that are proliferative and chemotactic, are able to
inhibit cytokine production, and may suppress differentiation of osteoclasts. The aim of this

study is to determine if the delivery of exosomes into rat calvarial defects will increase
regeneration by reducing the residual defect area and enhancing bone volume. Male SpragueDawley rats with bilateral 5mm surgically-created calvarial defects were randomized into groups
and treated with low- and high-dose exosome suspensions via a collagen gel matrix or a PBSsoaked collagen control. After 4 weeks, the calvaria were harvested and analyzed via micro
computed tomography (micro-CT). Volumetric micro-CT analysis showed that defects treated
with high-dose exosomes displayed a trend towards enhanced bone healing. Based on the results
of this pilot study, treatment with exosomes could be a promising therapeutic approach for
treatment of bone defects.
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Introduction
Periodontal disease is a chronic inflammatory condition that is the result of a bacterial
challenge in a susceptible host and affects the teeth, gingiva, periodontal ligament, and alveolar
bone. According to a recent CDC report, 46% of adults over 30 in the U.S. have some form of
periodontal disease.1 The aim of initial periodontal therapy is to reduce the bacterial load in the
oral cavity through methods of scaling and root planning, however further surgical intervention
is often necessary. The ultimate goal of periodontal treatment is the regeneration of the
periodontium, which includes the alveolar bone, periodontal ligament, and cementum. Some
clinical approaches to achieving regeneration of the periodontium include osseous grafting and
guided tissue regeneration (“GTR”). These techniques use a variety of grafts, including
autogenic, allogeneic, or xenogeneic bone and often combine them with other modalities such as
membranes, and/or biologically active agents, such as enamel matrix derivate and growth-factor
enhanced matrix containing platelet derived growth factor (rhPDGF-BB).2,3 In non-critically
sized periodontal defects, regeneration occurring via the bodies’ own intramembranous and
endochondral ossification produces bone with little scar tissue and almost indistinguishable
characteristics from surrounding native bone.4 In critically sized defects or where natural
regeneration is insufficient, clinicians may apply these regenerative techniques to augment bone
repair.

Derived from historical practices of tissue engineering and biological scaffolding, cell-based
regenerative medicine is drawing progressively more attention in recent years based upon its
great potential.5 Human mesenchymal stem cells (MSCs) show great promise in regenerative

medicine for their ability to enhance cell proliferation and differentiation, increase angiogenesis,
and modulate the immune response. Many of the regenerative properties of MSCs have been
demonstrated to be mediated though cell-derived by-products, known as exosomes.6 Exosomes
are a specific class of lipid-membrane-bound extracellular vesicles, ranging from 40-150nm in
diameter. They are produced by many cell types, contain various functional proteins, mRNAs,
microRNAs, and lipids, and play a critical role in cell-to-cell communication.7

Bioactive

molecules are encapsulated in these vesicles and are subsequently transferred to cells in the local
environment or distant organs, and may regulate the behavior of recipient cells. Exosome-based
therapies in animal models have been shown to promote the regeneration of tissues in various
organs, including the heart, kidney, skin, and nervous system by participating in important
pathways of development, organogenesis, wound healing, and regeneration.8–11 Their
regenerative potential may also be modulated by the exposure of the originating cell population
to external stimuli, such as hypoxia.12
Treatment with exosomes has some advantages over delivery of human cells, including
resistance to degradation, superior stability and durability, ease of storage, and lower potential
for immune rejection, and therefore may represent a generally non-cytotoxic and well-tolerated
regenerative therapy.6 The specific aim of this study is to determine if the delivery of exosomes
into rat calvarial defects will increase regeneration by reducing the residual defect area and
enhancing bone volume. This in vivo model consisted of creating 5mm bilateral calvarial defects
in male Sprague-Dawley rats, delivering high-dose or low-dose exosomes in collagen gel, or a
control gel without exosomes into the defects, and examining the defects after four weeks to
evaluate if exosomes exhibited induction of bone formation and promotion of bone healing.
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Male SpragueDawley Rats
N = 24 defects
(12 rats)

No Treatment Group
(Control)

Treatment Group

High Dose Exosome
(10 µg)
N = 8 defects
(4 rats)

Low Dose Exosome
(2 µg)
N = 8 defects
(4 rats)

Collagen soaked in
PBS
N = 8 defects
(4 rats)

Figure 1: Experimental Design. Flow chart depicting the division of 12 male Sprague-Dawley
rats into 24 randomized defects.
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Methods
Human bone marrow stromal cells were cultured with exosome-depleted media for 48
hours. The media were collected and exosomes were harvested by sequential ultracentrifugation
with the following protocol: cell debris and large cell fragments were removed first at a
gravitational force of 500g for 10 minutes; then at 2,000g for 10 minutes; and finally at 10,000g
for 30 minutes. Exosomes were then collected at 100,000g for 70 minutes and the pellets were
washed in 0.9% NaCl and centrifuged a second time at 100,000g for 70 minutes. The pellets
were then re-suspended in phosphate-buffered saline (PBS) and stored at -800C for the animal
experiment.
All procedures performed on animals followed protocols approved by the Institutional
Animal Care and Use Committee (IACUC) at Virginia Commonwealth University (Protocol
#AD10001541). Twelve male Sprague-Dawley rats (approximately 250 to 300 grams, aged 9 to
10 weeks) were divided into three groups: no treatment (collagen soaked in PBS), high-dose
exosome (collagen soaked in 10 µg exosomes), and low-dose exosome (collagen soaked in 2 µg
exosomes) (Figure 1). The rats were anesthetized with 4% isoflurane in O2 for induction and
then maintained at 1-3% isoflurane in O2. A subcutaneous injection of buprenorphine
(1.0mg/kg) was used for perioperative analgesia, after which the surgical site was shaved and
cleaned with betadine and 70% ethanol. Once the rats were transferred to the heated surgical
table and covered with sterile drapes, a linear scalp incision was made from the nasal bone to the
occiput, and full-thickness flaps were elevated. The periosteum overlying the calvarial bone was
completely reflected.
Trephine burs under copious irrigation were used to create bilateral 5mm craniotomy
defects in each rat, centered on each side of the parietal calvarial bone (Figures 2 and 3).

4

Attention was given to avoid damaging the sagittal suture. The calvarial disks were carefully
removed to prevent injury to the underlying dura or brain. The three groups were randomized
and defects were implanted with either high-dose (10 µg) or low-dose (2 µg) exosome
concentrates in a collagen gel, or a PBS soaked collagen matrix without exosomes to serve as the
control. The periosteum was sutured internally with interrupted sutures using 4-0 chromic gut,
and the incisions were closed with continuous interlocking sutures using 4-0 chromic gut sutures.
The closed surgical sites were cleaned again with betadine, and the rats were recovered from
anesthesia on a heating pad. One rat died during surgery from anesthetic complications; however
the remaining 11 rats convalesced with no post-operative complications. All rats were sacrificed
with carbon dioxide inhalation four weeks after implantation, and the calvaria were harvested
and fixed in 10% formalin.
Calvarial bone regeneration was quantified by the use of a Bruker Skyscan 1173 MicroCT (Billerica, MA). The harvested calvaria were scanned and raw images were generated. The
images were examined at thresholds ranging from 110-190 Hounsfield units (Hu) to further
exclude immature bone. A region of interest was generated using a cylindrical section with a
5mm radius to encompass the defect area exclusively. The quantification of new bone was
established through surface area regrowth percentage and total bone volume in mm3 at a
threshold of 110 Hu.
The two-dimensional data depicting surface area distribution was analyzed using Fisher’s
Exact test to evaluate differences in bone fill between treatment and control groups. Next, the
total bone volume in mm3 was analyzed using one-way analysis of variance (ANOVA), followed
by Bonferroni's multiple-comparison test. P<0.05 was considered to be statistical significance.

5

The results were expressed as means ± standard deviation, and graphs were prepared using
Graph Pad Prism 7.02 (Graph Pad Software, CA, USA).

Figure 2: Surgical Design. Rats received one of three possible configurations in both defects. The
no treatment group was treated with a PBS-soaked collagen gel vehicle to serve as control. The high dose exosome treatment group was treated with high-dose (10 µg) MSC exosome via collagen gel
matrix and the low-dose exosome treatment group was treated with low-dose (2 µg) MSC exosome
via collagen gel matrix.

Figure 3: Surgical Photos. a) Pre-operative photo: shaved rat calvaria with sterile drape in place
after betadine disinfection. b) Intra-operative photo: split-thickness dissection to access calvaria and
2x 5mm defects surgically created with trephine bur to remove thin disc of calvarial bone while
leaving underlying dura matter intact. c) Post-operative photo: primary closure with continuous
interlocking sutures with 4-0 chromic gut.
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Results
The first parameter measured in this study was the area of defect recovery following
different treatment modalities. The results demonstrated a relatively large variance in the area of
the defect covered by new bone (Figure 4). Surprisingly, most of the defects resulted in more
than 50% recovery. However, when further stratifying the healing into three different categories
(<80% recovery, 80-90% recovery, and >90% recovery), collagen soaked in high-dose exosomes
led to better bone healing, as evidenced by the finding that 4 out of the 8 defects exhibited
greater than 90% recovered surface area. In contrast, this observation was rare in the low-dose
exosome group (1 in 6 defects), and in the PBS-soaked collagen control group (0 in 8 defects)
(Figure 5). Stratifying the bone fill into three levels failed to achieve statistical significance
between the three groups (p=0.23). When bone fill was dichotomized into >90% and ≤90%,
however, significance was reached (p=0.04), further demonstrating better bone healing in the
high-dose exosome group (Figure 6).
Next, bone volume (mm3) was measured within the defect area. At the threshold of 110
Hu (a standard threshold for bone), it was observed that treatment with the high-dose exosome
appears to have higher bone volume than the other groups, although no statistical difference was
seen due to the small sample size (p= 0.48) (Figure 7). When a variety of thresholds were applied
to differentiate the maturity of the newly-formed bone, this trend was more prominent as the
threshold increased, suggesting that more mature bone was found in the high-dose exosome
group. Conversely, the low-dose exosome group did not appear to be much different from the
collagen gel control. In addition, there was a larger variance in the high-dose exosome group
compared to the control.
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Figure 4: 2D Surface Area Analysis. Surface area analysis comparing the collagen gel control,
high-dose exosome, and low-dose exosome groups at a threshold of 180 Hu. The 5mm defect is
represented by the circle above, with the bone fill being depicted in yellow and absence of bone
(likely soft tissue in-growth) is depicted in red.

Figure 5: Surface Area Distribution. Bar graphs depicting three parameters of the recovered
surface area of bone per number of defects for collagen control, high-dose exosome (10 µg), and
low-dose exosome (2 µg) groups
8

Figure 7: Surface Area Distribution. Bar graphs depicting three parameters of the recovered
surface area of bone per number of defects for collagen control, high-dose exosome (10 µg), and
low-dose exosome (2 µg) groups

Figure 6: Volumetric Measurements at Varying Thresholds. Scatter plots showing bone
volume in mm3 at thresholds 110, 130, 150, and 170 for collagen control, high-dose exosome
(10 µg), and low-dose exosome (2 µg) groups.
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Discussion
Bone grafting with autogenous and non-autogenous grafts remains the standard of care in
human bone regeneration, but limitations persist, particularly in the recovery time and associated
morbidity of the procedure. Human mesenchymal stem cells show great potential in regeneration
due to their ability to enhance cell proliferation and differentiation, increase angiogenesis, and
modulate the immune response. In this study, more defects treated with high-dose (10 µg) MSC
exosomes achieved greater than 90% surface recovery as compared to the low-dose (2 µg) and
control groups. As assessed using 3-D measurement, greater bone volume overall was seen in the
high-dose exosome group, although this was not statistically significant (p=0.48). When the
thresholds for bone tissue were adjusted, the differences between the high-dose group and
control group appeared to be greater, suggesting that exosome treatment may be associated with
more mature bone formation. The four-week time period of this study, however, may have been
too short. At four weeks, most of the regenerated bone may have consisted of woven, or
immature, bone.13,14 This is based on the knowledge that it takes approximately 38 days to for a
human extraction socket to become 2/3 filled with trabecular bone, and human intra-bony defects
can take anywhere from 2-3 months to heal completely, based on histologic evidence.15 Thus,
longer time points may help us better understand the potential effects of exosomes on the
maturation bony defects.
Many defect healing studies use bone volume recovery as a benchmark for healing,
however volume recovery measurements alone do not adequately explain the nature of the bone
healing that occurs in this model. The geographic pattern of new bone formation in these defects
is another important consideration that may contribute to understanding bone healing. In critical
size defect models, center healing is typically considered the most difficult to achieve and may
10

be a valuable benchmark for measuring defect healing with full-width viewing. In this study,
data from a side by side comparison of the high-dose and low-dose exosome groups versus the
collagen control group indicated that more defects treated with exosomes exhibited coverage at
the center of the circular defects than those in the collagen group (Figure 4). In a separate but
similar study, the 5mm circular calvarial defect was treated with high-dose exosomes or a
collagen gel control. A more in-depth micro-CT examination of the defects was performed. In
this case, the 5mm defects were examined at sequentially smaller disc-shaped zones of 4, 3, 2,
and 1mm diameters that originated from the defect center to investigate bone regeneration
patterns.16 This division was done with the knowledge that the defect center, which is the furthest
point away from the scaffold of native bone, is typically the most challenging area to treat. When
the defect area was separated into these smaller zones, a pattern of enhanced bone healing
appeared towards the center of the defect, and greater regeneration was observed in the exosome
groups as compared to the collagen groups, with this difference becoming greater with increased
proximity to the defect center. Those findings were consistent with what was observed in this
study.
Several studies have been published that document the benefits of exosomes and the
potential applications of exosome therapy in dentistry. A study by Chew et al in 2019 examined
the effects of human MSC exosome-loaded collagen sponge on periodontal regeneration of
surgically created intrabony defects in an immunocompetent rat model.17 The defects treated
with collagen sponges loaded with exosomes showed a reduction in the size of the bone defect in
comparison to the collagen sponge alone and untreated groups. Exosome-treated rats had more
effective repair of the defects with regeneration of newly formed bone and periodontal ligament.
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It was concluded that exosomes enhanced regeneration through increased cellular migration,
proliferation, synthesis, and differentiation into new bone and PDL.
Qi et al measured the effect of critical size calvarial defects in Sprague-Dawley rats
treated with β-TCP loaded with high-dose or low-dose exosomes as compared to β-TCP alone.7
Similar to the trend observed in this study, the β-TCP group treated with high-dose exosome
exhibited more newly formed bone and higher bone density. Additionally, both the high-dose
and low-dose exosome β-TCP groups showed increased neo-angiogenesis as compared to β-TCP
treatment alone. In another study, Liang et al examined the effects of pretreating stem cells with
Dimethyloxaloylglycine (DMOG), a molecule that inhibits the ability of prolyl hydroxylase to
regulate the stability of HIF-1α, thereby mimicking hypoxia in cells under normal oxygen
levels.18 Based on the knowledge that exposure to oxidative stress induces the expression of
proangiogenic proteins, that study examined the effects of treatment with DMOG on increased
angiogenesis and bone regeneration in a critical size calvarial defect rat model. The results of the
study demonstrated more newly formed bone in the DMOG treated exosome group, markedly
higher new bone volume relative to tissue volume, and greater neovascularization. In summary,
the addition of DMOG to MSC exosomes is a promising pretreatment for exosome-based
approaches to treating bone defects.

Mohammed studied the effects of using exosomes as an adjunct to nonsurgical
periodontal therapy versus scaling and root planing alone in a rat ligature model.19 The authors
found that the exosome group exhibited the least amount of inflammatory infiltrate and
demonstrated signs of new periodontal tissue formation at two days. At two weeks, the exosome
group showed the greatest degree of proliferation in periodontal tissues with increased cellularity
and organization, and at four weeks the exosome group showed the most significant signs of
12

healing. Based on these results, adjunctive exosome treatment is a promising regenerative
technique to enhance therapeutic outcomes of nonsurgical periodontal therapy.

The results of the current study are in line with aforementioned observations. The
primary aim of this pilot study was to determine the appropriate dose of exosomes in future
calvarial defect model studies. Power analysis was conducted based on preliminary results and if
the volume of newly-formed bone is used as the primary outcome, achieving a level of statistical
significance in future studies would require a sample size of 11 per group to achieve a type I
error rate of less than 5%, given the same defect size and with sufficient power (80%). Similarly,
because there was not a large difference between the low-dose exosome group and the collagen
control group, future studies may be conducted to compare only two groups, the high-dose
exosome group and the collagen group while also incorporating a negative or empty control.
Another possibility for future studies would be to use Sprague-Dawley rats that are older. In this
study the rats were between 9 and 10 weeks old, at which point they exhibit a very strong natural
growth ability and regenerative potential. This may imply that older rats be used in future studies
to minimize the effects of the strong natural regenerative potential observed in younger rats.

Finally, one may question whether the defects created in this study were truly critical size
defects. By definition, a critical size defect is one that will not fully regenerate in the natural
lifetime of the animal.20 While some studies propose that the 5mm defect is critically sized,
others advocate for an 8mm critical defect in rat calvaria.21 In this study, the natural regenerative
potential in the collagen control groups after only four weeks of healing indicates that the defect
model in this study is not critically sized. In the future, larger defects should be considered.
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Conclusion
Defects treated with high-dose MSC exosomes demonstrated a trend towards enhanced
healing, structural integrity, and growth uniformity in a calvarial defect model. Based on the
results of this pilot study, treatment with MSC exosomes could be a promising therapeutic
approach for treatment of bone defects.
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